BUZZ-Valeant Pharmaceuticals: Names new CFO, shares up

Mon Aug 22, 2016 6:36am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian drugmaker's U.S. listed shares up 5.2 pct at $30.24 premarket

** Valeant names ex-Zoetis finance chief Paul Herendeen as CFO in latest management shakeup

** Current CFO Robert Rosiello to now lead development and strategy

** Valeant, which is facing intense investor and regulatory scrutiny over its business and accounting practices, named a new general counsel earlier this month and a new CEO in April

** Up to Friday's close, stock had fallen nearly 72 pct YTD